Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 162

1.

Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis.

Krediet RT.

Front Physiol. 2018 Dec 20;9:1815. doi: 10.3389/fphys.2018.01815. eCollection 2018. Review.

2.

Early Detection of Imminent Encapsulating Peritoneal Sclerosis: Free Water Transport, Selected Effluent Proteins, or Both?

Barreto DL, Sampimon DE, Struijk DG, Krediet RT.

Perit Dial Int. 2019 Jan-Feb;39(1):83-89. doi: 10.3747/pdi.2017.00194. Epub 2018 Nov 25.

PMID:
30478138
3.

Should End-of-Life Preferences Be Discussed Routinely before High-Risk Surgery?

Doherty DT, Shapey IM, Moinuddin Z, Birtles L, Summers A, Ahamed A, van Dellen D, Augustine T.

J Palliat Med. 2018 Oct 4. doi: 10.1089/jpm.2018.0048. [Epub ahead of print]

PMID:
30285534
4.

Encapsulating peritoneal sclerosis following hyperthermic intraperitoneal chemotherapy.

Mangan C, Moinuddin Z, Summers A, de Reuver P, van Dellen D, Augustine T.

ANZ J Surg. 2018 Sep 2. doi: 10.1111/ans.14770. [Epub ahead of print] No abstract available.

PMID:
30173413
5.

Biocompatible Solutions and Long-Term Changes in Peritoneal Solute Transport.

Elphick EH, Teece L, Chess JA, Do JY, Kim YL, Lee HB, Davison SN, Topley N, Davies SJ, Lambie M.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1526-1533. doi: 10.2215/CJN.02380218. Epub 2018 Aug 31.

PMID:
30171050
6.

Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis: In Vitro Downregulation by Vitamin D Receptor Agonists.

Ossorio M, Martínez V, Bajo MA, Del Peso G, Castro MJ, Romero S, Selgas R, Bellón T.

Biomed Res Int. 2018 Apr 4;2018:6415892. doi: 10.1155/2018/6415892. eCollection 2018.

7.

A Large Intraperitoneal Residual Volume Hampers Adequate Volumetric Assessment of Osmotic Conductance to Glucose.

Clause AL, Keddar M, Crott R, Darius T, Fillee C, Goffin E, Morelle J.

Perit Dial Int. 2018 Sep-Oct;38(5):356-362. doi: 10.3747/pdi.2017.00219. Epub 2018 Apr 19.

PMID:
29674410
8.

Absence of Post-Transplantation Encapsulating Peritoneal Sclerosis after Relatively Short Exposure to Peritoneal Dialysis: Prospective Analysis Using Repeated Abdominal CT Scanning.

Abrahams AC, van Gelder MK, van der Veer JW, de Jong PA, van Leeuwen MS, Boer WH.

Perit Dial Int. 2017 Jul-Aug;37(4):443-450. doi: 10.3747/pdi.2016.00238.

PMID:
28676511
9.

A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.

Zavvos V, Buxton AT, Evans C, Lambie M, Davies SJ, Topley N, Wilkie M, Summers A, Brenchley P, Goumenos DS, Johnson TS.

Kidney Int. 2017 Oct;92(4):988-1002. doi: 10.1016/j.kint.2017.03.030. Epub 2017 Jul 1.

10.

The truth on current peritoneal dialysis: state of the art.

Krediet RT, Abrahams AC, de Fijter CWH, Betjes MGH, Boer WH, van Jaarsveld BC, Konings CJAM, Dekker FW.

Neth J Med. 2017 Jun;75(5):179-189. Review.

11.

Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis.

Ossorio M, Bajo MA, Del Peso G, Martínez V, Fernández M, Castro MJ, Rodríguez-Sanz A, Madero R, Bellón T, Selgas R.

PLoS One. 2017 Apr 17;12(4):e0175835. doi: 10.1371/journal.pone.0175835. eCollection 2017.

12.

Significant Decreasing Incidence of Encapsulating Peritoneal Sclerosis in the Dutch Population of Peritoneal Dialysis Patients.

Betjes MG, Habib SM, Boeschoten EW, Hemke AC, Struijk DG, Westerhuis R, Abrahams AC, Korte MR.

Perit Dial Int. 2017 Mar-Apr;37(2):230-234. doi: 10.3747/pdi.2016.00109.

PMID:
28360369
13.

No Relation Between Peritoneal Fibrosis and Free Water Transport in a Rat Model.

Krediet RT, Vlahu CA, Barreto DL, Struijk DG.

Adv Perit Dial. 2017 Jan;33(2017):13-17.

PMID:
29668424
14.

The number of patients with severe encapsulating peritoneal sclerosis is decreasing in a large referral center in Germany.

Kitterer D, Braun N, Alscher MD, Segerer S, Latus J.

Int J Nephrol Renovasc Dis. 2016 Aug 5;9:183-6. doi: 10.2147/IJNRD.S108529. eCollection 2016.

15.

Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.

Zhou Q, Bajo MA, Del Peso G, Yu X, Selgas R.

Kidney Int. 2016 Sep;90(3):515-24. doi: 10.1016/j.kint.2016.03.040. Epub 2016 Jun 7. Review.

PMID:
27282936
16.

Unraveling the mechanisms of progressive peritoneal membrane fibrosis.

Davies SJ.

Kidney Int. 2016 Jun;89(6):1185-7. doi: 10.1016/j.kint.2016.02.029.

PMID:
27181773
17.

Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis.

Liappas G, González-Mateo GT, Sánchez-Díaz R, Lazcano JJ, Lasarte S, Matesanz-Marín A, Zur R, Ferrantelli E, Ramírez LG, Aguilera A, Fernández-Ruiz E, Beelen RH, Selgas R, Sánchez-Madrid F, Martín P, López-Cabrera M.

J Am Soc Nephrol. 2016 Dec;27(12):3561-3576. Epub 2016 May 5.

18.

New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum.

Vlahu CA, Aten J, de Graaff M, van Veen H, Everts V, de Waart DR, Struijk DG, Krediet RT.

Perit Dial Int. 2016 11-12;36(6):614-622. Epub 2016 May 4.

19.

Identification of Gene Transcripts Implicated in Peritoneal Membrane Alterations.

Parikova A, Vlijm A, Brabcova I, de Graaff M, Struijk DG, Viklicky O, Krediet RT.

Perit Dial Int. 2016 11-12;36(6):606-613. Epub 2016 May 4.

20.

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.

Liappas G, González-Mateo G, Aguirre AR, Abensur H, Albar-Vizcaino P, Parra EG, Sandoval P, Ramírez LG, Del Peso G, Acedo JM, Bajo MA, Selgas R, Sánchez Tomero JA, López-Cabrera M, Aguilera A.

Oncotarget. 2016 May 24;7(21):30133-46. doi: 10.18632/oncotarget.8780. Erratum in: Oncotarget. 2017 Apr 4;8(14 ):24045.

Supplemental Content

Loading ...
Support Center